End Taxpayer Funding of Gender Experimentation Act of 2025
About This Bill
Committee
Latest Action · March 18, 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
This bill prohibits the use of any federal funds to pay for gender transition procedures, defined broadly to include hormone treatments, puberty-blocking drugs, and surgical interventions. The prohibition applies to all federal programs and agencies, including the military, Veterans Affairs, Medicare, and Medicaid, as well as federal employee health plans. The bill also prevents federal tax credits under the Affordable Care Act from being used for health insurance plans that cover gender transition procedures. However, the legislation includes exceptions for treating complications from transition procedures, addressing disorders of sex development, and treating other serious medical conditions unrelated to gender transition. States and individuals may purchase separate coverage for these procedures using entirely non-federal funds, but they cannot use federal matching funds or subsidies. The restrictions on tax credits take effect one year after the bill's enactment for plan years beginning after that date. The bill does not prevent private insurers or employers from offering such coverage, as long as no federal funds support it.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.